These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 11470758)

  • 41. Accelerated degradation of cellular FLIP protein through the ubiquitin-proteasome pathway in p53-mediated apoptosis of human cancer cells.
    Fukazawa T; Fujiwara T; Uno F; Teraishi F; Kadowaki Y; Itoshima T; Takata Y; Kagawa S; Roth JA; Tschopp J; Tanaka N
    Oncogene; 2001 Aug; 20(37):5225-31. PubMed ID: 11526513
    [TBL] [Abstract][Full Text] [Related]  

  • 42. p53 gene family p51(p63)-encoded, secondary transactivator p51B(TAp63alpha) occurs without forming an immunoprecipitable complex with MDM2, but responds to genotoxic stress by accumulation.
    Okada Y; Osada M; Kurata S; Sato S; Aisaki K; Kageyama Y; Kihara K; Ikawa Y; Katoh I
    Exp Cell Res; 2002 Jun; 276(2):194-200. PubMed ID: 12027449
    [TBL] [Abstract][Full Text] [Related]  

  • 43. BTG gene expression in the p53-dependent and -independent cellular response to DNA damage.
    Cortes U; Moyret-Lalle C; Falette N; Duriez C; Ghissassi FE; Barnas C; Morel AP; Hainaut P; Magaud JP; Puisieux A
    Mol Carcinog; 2000 Feb; 27(2):57-64. PubMed ID: 10657898
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Adhesion-regulated G1 cell cycle arrest in epithelial cells requires the downregulation of c-Myc.
    Benaud CM; Dickson RB
    Oncogene; 2001 Jul; 20(33):4554-67. PubMed ID: 11494151
    [TBL] [Abstract][Full Text] [Related]  

  • 45. hZIP1 zinc uptake transporter down regulation and zinc depletion in prostate cancer.
    Franklin RB; Feng P; Milon B; Desouki MM; Singh KK; Kajdacsy-Balla A; Bagasra O; Costello LC
    Mol Cancer; 2005 Sep; 4():32. PubMed ID: 16153295
    [TBL] [Abstract][Full Text] [Related]  

  • 46. [Enhancement of B-cell translocation gene-2 inhibits proliferation and metastasis of colon cancer cells].
    Jiang Z; Zhang L; Zhang L; Wang S; Zheng M; Li Y; Liu X
    Zhonghua Zhong Liu Za Zhi; 2015 May; 37(5):330-5. PubMed ID: 26463021
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Role of Btg2 in the progression of a PDGF-induced oligodendroglioma model.
    Appolloni I; Curreli S; Caviglia S; Barilari M; Gambini E; Pagano A; Malatesta P
    Int J Mol Sci; 2012 Nov; 13(11):14667-78. PubMed ID: 23203087
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Nuclear and cytoplasmic degradation of endogenous p53 and HDM2 occurs during down-regulation of the p53 response after multiple types of DNA damage.
    Joseph TW; Zaika A; Moll UM
    FASEB J; 2003 Sep; 17(12):1622-30. PubMed ID: 12958168
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Kip1 degradation via the ubiquitin-proteasome pathway.
    Tam SW; Theodoras AM; Pagano M
    Leukemia; 1997 Apr; 11 Suppl 3():363-6. PubMed ID: 9209391
    [TBL] [Abstract][Full Text] [Related]  

  • 50. BTG2 antiproliferative protein interacts with the human CCR4 complex existing in vivo in three cell-cycle-regulated forms.
    Morel AP; Sentis S; Bianchin C; Le Romancer M; Jonard L; Rostan MC; Rimokh R; Corbo L
    J Cell Sci; 2003 Jul; 116(Pt 14):2929-36. PubMed ID: 12771185
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Inhibitors of transcription, proteasome inhibitors, and DNA-damaging drugs differentially affect feedback of p53 degradation.
    An WG; Chuman Y; Fojo T; Blagosklonny MV
    Exp Cell Res; 1998 Oct; 244(1):54-60. PubMed ID: 9770348
    [TBL] [Abstract][Full Text] [Related]  

  • 52. p53 overexpression represses androgen-mediated induction of NKX3.1 in a prostate cancer cell line.
    Jiang A; Yu C; Zhang P; Chen W; Liu W; Hu X; Zhang J
    Exp Mol Med; 2006 Dec; 38(6):625-33. PubMed ID: 17202838
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Inhibition of TNFα-interacting protein α (Tipα)-associated gastric carcinogenesis by BTG2
    Devanand P; Oya Y; Sundaramoorthy S; Song KY; Watanabe T; Kobayashi Y; Shimizu Y; Hong SA; Suganuma M; Lim IK
    Exp Mol Med; 2018 Feb; 50(2):e449. PubMed ID: 29472702
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Geldanamycin-stimulated destabilization of mutated p53 is mediated by the proteasome in vivo.
    Whitesell L; Sutphin P; An WG; Schulte T; Blagosklonny MV; Neckers L
    Oncogene; 1997 Jun; 14(23):2809-16. PubMed ID: 9190897
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Maspin is up-regulated in premalignant prostate epithelia.
    Pierson CR; McGowen R; Grignon D; Sakr W; Dey J; Sheng S
    Prostate; 2002 Dec; 53(4):255-62. PubMed ID: 12430137
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Deoxycholic acid suppresses p53 by stimulating proteasome-mediated p53 protein degradation.
    Qiao D; Gaitonde SV; Qi W; Martinez JD
    Carcinogenesis; 2001 Jun; 22(6):957-64. PubMed ID: 11375905
    [TBL] [Abstract][Full Text] [Related]  

  • 57. [Mechanisms of BTG2 activity, a transcriptional target of p53: evidences and hypothesis].
    Puisieux A; Magaud JP
    Bull Cancer; 1999 Apr; 86(4):358-64. PubMed ID: 10341341
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Retinoic acid-mediated G1-S-phase arrest of normal human mammary epithelial cells is independent of the level of p53 protein expression.
    Seewaldt VL; Dietze EC; Johnson BS; Collins SJ; Parker MB
    Cell Growth Differ; 1999 Jan; 10(1):49-59. PubMed ID: 9950218
    [TBL] [Abstract][Full Text] [Related]  

  • 59. MiR-6875-3p promotes the proliferation, invasion and metastasis of hepatocellular carcinoma via BTG2/FAK/Akt pathway.
    Xie Y; Du J; Liu Z; Zhang D; Yao X; Yang Y
    J Exp Clin Cancer Res; 2019 Jan; 38(1):7. PubMed ID: 30621734
    [TBL] [Abstract][Full Text] [Related]  

  • 60. BTG2: a rising star of tumor suppressors (review).
    Mao B; Zhang Z; Wang G
    Int J Oncol; 2015 Feb; 46(2):459-64. PubMed ID: 25405282
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.